We have a culture that inspires intellectual curiosity and flexibility.

Counterpoint Global, one of our Active Fundamental Equity teams, seeks to make long-term investments in unique companies whose market value can increase significantly for underlying fundamental reasons. Their portfolios are typically concentrated and differentiated from their benchmarks. Counterpoint Global consists of 56 people, including 32 investors, four disruptive change researchers, two consilient researchers and two sustainability researchers. Counterpoint Global’s culture fosters collaboration, creativity, continued development, and differentiated thinking.

The Counterpoint Global platform includes the Global Opportunity^ investment team, led by Kristian Heugh. 

Counterpoint Global
 
 
 
 
Strategies
LEAD MANAGER: Dennis Lynch
Invests primarily in established and emerging companies globally.  
Invests primarily in established companies globally that benefit from efficient scale.  
Invests primarily in established and emerging small cap companies in the United States.  
Invests primarily in established and emerging mid cap companies in the United States.  
Invests primarily in established and emerging large cap companies in the United States.  
Invests primarily in established and emerging companies in the United States.  
Invests primarily in established large cap companies in the United States.  
Invests primarily in established and emerging companies globally.  
Invests primarily in established companies in the United States that benefit from efficient scale.  
LEAD MANAGER: Kristian Heugh
Invests in high quality established and emerging companies located in Asia (excluding Japan) that the team believes are undervalued at the time of investment.  
Invests in high quality companies located or operating in developing or emerging market countries that the team believes are undervalued at the time of investment.  
Invests in high quality companies located or operating in developed market countries that the team believes are undervalued at the time of investment.  
Invests in high quality established and emerging companies located in Europe that the team believes are undervalued at the time of investment.  
Invests globally in high quality companies with strong ESG alignment consistent with the United Nations Sustainable Development Goals that the team believes are undervalued at the time of investment. Restricts businesses operating in industries with material environmental and social externalities and/or corporate governance risk, including alcohol, tobacco, fossil fuels and weapons.  
Invests globally in high quality established and emerging companies that the team believes are undervalued at the time of investment.  
Invests internationally in high quality established companies that the team believes are undervalued at the time of investment.  
Invests internationally in high quality established and emerging companies that the team believes are undervalued at the time of investment.  
LEAD MANAGER: Manas Gautam
Invests primarily in companies with growing intrinsic value.  
LEAD MANAGERS: Anne Edelstein & Jenny Leeds, Ph.D.
Invests primarily in companies principally engaged in the discovery, development, production, or distribution of products or services related to advances in healthcare.  
 

Subscribe to Counterpoint Global Insights - Consilient Observer

Please enter the code sent to your email address.

Valid for 10 minutes only

Confirm
Email Not Sent
 
 
Submit
 
 
 

 

当ページの情報は、モルガン・スタンレー・インベストメント・マネジメント株式会社(以下、当社)が、投資一任契約においてご提供する運用プロダクトに関連する情報提供を目的として作成したものです。本資料は当社が信頼できると判断した情報を元に、十分な注意を払い作成しておりますが、当社はその正確性や完全性をお約束するものではありません。

 

This is a Marketing Communication.

モルガン・スタンレー・インベストメント・マネジメント株式会社
金融商品取引業者 関東財務局長(金商)第410号

加入協会:日本証券業協会、一般社団法人投資信託協会、
一般社団法人日本投資顧問業協会、一般社団法人第二種金融商品取引業協会


プライバシー・ステートメント    •    利用条件    •    オフィス所在地    •    日本におけるモルガン・スタンレー

©  Morgan Stanley. All rights reserved.